MERCK RECEIVES POSITIVE EU CHMP OPINION FOR WELIREG® (BELZUTIFAN) IN COMBINATION WITH LENVATINIB FOR ADULTS WITH ADVANCED RENAL CELL CARCINOMA WITH A CLEAR CELL COMPONENT (CCRCC) FOLLOWING TREATMENT WITH AN ANTI-PD-1/PD-L1 THERAPY

Reuters · 1d ago

Please log in to view news